Punch & Associates Investment Management’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
Other funds holding KYNB
HA
Punch & Associates Investment Management's KYNB Position: Q1 2021 in Review
Punch & Associates Investment Management sold out of Kyntra Bio (KYNB) in Q1 2021, closing a stake of 360 shares — an estimated $334K sold.
Punch & Associates Investment Management first reported a position in KYNB in Q2 2015 and held it in 23 quarters. The position peaked at $1.22M in Q4 2015. 198 funds tracked by Wall St. Rank hold KYNB as of Q1 2021.
- Punch & Associates Investment Management reported no remaining Kyntra Bio position as of Q1 2021 after selling out during the quarter.
- Punch & Associates Investment Management sold 360 Kyntra Bio shares in Q1 2021, an estimated $334K.
- Punch & Associates Investment Management first reported a position in Kyntra Bio in Q2 2015 and held it in 23 quarters.
- Punch & Associates Investment Management's Kyntra Bio position peaked at $1.22M in Q4 2015.
- 198 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2021.
Based on Punch & Associates Investment Management's 13F filing for Q1 2021, filed 18 May 2021.